Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8V5H

Crystal structure of MASTL Kinase domain in complex with an inhibitor

This is a non-PDB format compatible entry.
Summary for 8V5H
Entry DOI10.2210/pdb8v5h/pdb
DescriptorSerine/threonine-protein kinase greatwall, (3M)-N~6~-ethyl-3-(1-methyl-1H-imidazol-5-yl)-2,7-naphthyridine-1,6-diamine (2 entities in total)
Functional Keywordshuman greatwall, kinase, mastl kinase domain, inhibitor, transferase, transferase-inhibitor complex, transferase/inhibitor
Biological sourceHomo sapiens (human)
More
Total number of polymer chains1
Total formula weight38658.08
Authors
Greasley, S.E.,Diehl, W. (deposition date: 2023-11-30, release date: 2025-01-22)
Primary citationGallego, R.A.,Scales, S.,Toledo, C.,Auth, M.,Bernier, L.,Berry, M.,Brun, S.,Chung, L.,Davis, C.,Diehl, W.,Dress, K.,Eisele, K.,Elleraas, J.,Ewanicki, J.,Fobian, Y.,Greasley, S.,Greenwald, E.C.,Johnson, T.W.,Khamphavong, P.,Lafontaine, J.,Li, J.,Linton, A.,Maestre, M.,Miller, N.,Murtaza, A.,Patman, R.L.,Quinlan, C.L.,Ramms, D.J.,Richardson, P.,Sach, N.,Salomon-Ferrer, R.,Silva, F.,Timofeevski, S.,Tran, P.,Tran-Dube, M.,Wang, F.,Wang, W.,Wythes, M.,Yang, S.,Zou, A.,VanArsdale, T.,McAlpine, I.
Discovery of Highly Selective Inhibitors of Microtubule-Associated Serine/Threonine Kinase-like (MASTL).
J.Med.Chem., 67:19234-19246, 2024
Cited by
PubMed Abstract: By virtue of its role in cellular proliferation, microtubule-associated serine/threonine kinase-like (MASTL) represents a novel target and a first-in-class (FIC) opportunity to provide a new impactful therapeutic agent to oncology patients. Herein, we describe a hit-to-lead optimization effort that resulted in the delivery of two highly selective MASTL inhibitors. Key strategies leveraged to enable this work included structure-based drug design (SBDD), analysis of lipophilic efficiency (LipE) and novel synthesis. The resulting advanced lead compounds enabled a tumor growth inhibition study which was pivotal in assessing the potential value of MASTL as an oncology therapeutic target.
PubMed: 39499084
DOI: 10.1021/acs.jmedchem.4c01659
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.74 Å)
Structure validation

236620

PDB entries from 2025-05-28

PDB statisticsPDBj update infoContact PDBjnumon